Real-world evidence (RWE) studies are gaining increasing importance in medical research because they investigate drug therapy use under everyday conditions. Two recent RWE studies in the field of self ...
The use of ambroxol is recommended by the German Society for Pneumology and Respiratory Medicine [1] to reduce symptom intensity and accelerate the recovery from acute and subacute cough. As mucoactiv ...
A stressz negatív hatással lehet a kognitív funkciókra. Ez a másodlagos elemzés, mely egy randomizált, kettős vak, placebo-kontrollos, mérsékelten stresszes, egészséges felnőtteken végzett vizsgálatbó ...
Headache affects many people and can – in most cases – be successfully treated with over-the-counter analgesics. What are the patients’ characteristics? How do they experience the effects of the treat ...
The gut microbiome is unique to each person and has a major impact on health. Orally administered probiotics are used to prevent and/or treat gastrointestinal (GI) disorders and additionally show pote ...
Szerző: Paolo Pellegrino, MD, Maria Chiara Uboldi, PhD, Daniel Marquez és Marcos III PerezEFSM: 2024;4:240013DOI: 10.52778/efsm.24.0013Dátum: 05.03.2024
A recent study based on the National Health and Wellness Survey, the world’s largest online database of patient-reported health outcomes, found that low vitality negatively impacts quality of life, da ...
Magnesium (Mg) plays a vital role in maintaining bodily functions; in consequence, its deficiency has been linked to various chronic diseases. Diagnosis of Mg deficiency is challenging due to the ...
Clinical trial demonstrating non-inferiority of Poliprotect for heartburn and epigastric pain in patients without erosive esophagitis
A randomised, controlled, multicentre, double-blind and double-masked study confirmed the efficacy of Poliprotect®, a molecular complex of natural ingredients designed for the protection of the gastro ...
Musculoskeletal (MSK) disorders are the leading cause of chronic pain, physical, functional impairment and loss of quality of life. About one in three people worldwide is suffering from MSK pain. The ...
Szerző: Bill Giannakopoulos, PharmD, Mohamed Amessou, PhD, MBA és Eva Koscova, MD, PhD, MBA, CVTI SREFSM: 2023;3:230049DOI: 10.52778/efsm.23.0049Dátum: 17.12.2023
In self-limiting diseases such as acute respiratory infections, patients primarily expect relief of their symptoms, the aim being to reduce suffering and thus improve their quality of life. The result ...